Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity

Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main cause of anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this context. On the other hand, obesity is a known risk thromboembolic factor. In the clinical trials that led to the approval of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Almenzar, Begoña, Cerezo-Manchado, Juan José, García-Candel, Faustino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603013/
https://www.ncbi.nlm.nih.gov/pubmed/34825048
http://dx.doi.org/10.1016/j.ijcha.2021.100913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603013/
https://www.ncbi.nlm.nih.gov/pubmed/34825048
http://dx.doi.org/10.1016/j.ijcha.2021.100913

Ejemplares similares